Company

Ping An Biomedical Signs $2.3M Agreement To Acquire Three Oncology And Biotechnology Patents From Future Biotechnology Group

Nov 4, 2026 · 01:31 PM ET· updated 1h ago

Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (the "Company") today announced that it has entered into a definitive purchase agreement (the "Agreement") with Future Biotechnology Group Co., Limited for the

Why It Matters

Ping An Biomedical is buying cancer medicine patents for $2.3 million. When a company buys patents, watch if they use them to make new medicines or just collect them.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

PASW2.56

-2.40 (-48.39%)

MMM194.51

+17.45 (+9.86%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.